Marković, D., Jevtović-Stoimenov, T., Ćosić, V., Stošić, B., Dinić, V., Marković-Živković, B., & Janković, R. J. (2018). Clinical Utility of Survivin (BIRC5), Novel Cardiac Biomarker, as a Prognostic Tool Compared to High-sensitivity C-reactive Protein, Heart-type Fatty Acid Binding Protein and Revised Lee Score in Elderly Patients Scheduled for Major Non-cardiac Surgery: A Prospective Pilot Study. J Med Biochem.

Marković, Danica, Tatjana Jevtović-Stoimenov, Vladan Ćosić, Biljana Stošić, Vesna Dinić, Bojana Marković-Živković, a Radmilo J. Janković. "Clinical Utility of Survivin (BIRC5), Novel Cardiac Biomarker, As a Prognostic Tool Compared to High-sensitivity C-reactive Protein, Heart-type Fatty Acid Binding Protein and Revised Lee Score in Elderly Patients Scheduled for Major Non-cardiac Surgery: A Prospective Pilot Study." J Med Biochem 2018.

Marković, Danica, et al. "Clinical Utility of Survivin (BIRC5), Novel Cardiac Biomarker, As a Prognostic Tool Compared to High-sensitivity C-reactive Protein, Heart-type Fatty Acid Binding Protein and Revised Lee Score in Elderly Patients Scheduled for Major Non-cardiac Surgery: A Prospective Pilot Study." J Med Biochem 2018.